JMP Securities Maintains Market Outperform on Prothena Corp, Lowers Price Target to $81
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jason Butler maintains a Market Outperform rating on Prothena Corp (NASDAQ:PRTA) but lowers the price target from $83 to $81.
November 03, 2023 | 7:48 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Prothena Corp's price target has been lowered from $83 to $81 by JMP Securities, though the Market Outperform rating is maintained.
The news directly pertains to Prothena Corp (PRTA) as JMP Securities has lowered its price target for the company. However, the Market Outperform rating is maintained, indicating that the analyst still expects the stock to outperform the market. This could have a neutral impact on the stock's price in the short term as the lowered price target might be offset by the maintained positive rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100